EVO

EVO

Evotec SE ADR

Evotec SE is a drug discovery and development company that partners with pharmaceutical and biotechnology firms to create innovative therapeutics across multiple areas, including oncology, immunology, and metabolic diseases, serving both clinical and research needs.

βš•οΈ Healthcare NASDAQ Listed 2009 € EUR
$1,000 invested 20 years ago β†’$682today

Score Overview

1 Year
Score
Net Growth42.22%
Net TrendGrew
Net Income Consistencyβ€”
Rev Growth10.83%
Rev TrendGrew
Revenue Consistencyβ€”
5 Years
Score4.7
Net Growth-126.66%
Net Trend60%
Net Income Consistencyβ€”
Rev Growth35.80%
Rev Trend80%
Revenue Consistencyβ€”
10 Years
Score
Net Growth-308.70%
Net Trend50%
Net Income Consistency
Rev Growth410.19%
Rev Trend90%
Revenue Consistency
All Time
Score
Net Growth-26.28%
Net Trend59%
Net Income Consistency
Rev Growth19x
Rev Trend88%
Revenue Consistency

See the full market ranking β†’

Evotec SE ADR fundamental performance

Between 2020 and 2025, revenue grew from € 500M to € 757M and net income went from € 6M to -€ 99M. Revenue increased in 4 of those 5 years; net income in 3.

Across Evotec SE ADR's full reported history, from 2009 to 2025, revenue grew from € 42M to € 757M and net income went from -€ 45M to -€ 99M. Revenue increased in 88% of the years measured; net income in 59%.

Evotec SE ADR currently holds a 5-year HDB Score of 4.7 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 2.19β€”
1 Year2025-08-12
$ 3.81-42.52%
5 Years2021-08-12
$ 23.55-90.70%
10 Years2016-08-12
$ 1.9711.10%
20 Years2006-08-11
$ 3.21-31.84%
All Time2009-12-04
$ 0.86153.44%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026€ 839M-€ 57M€ 476M
2025€ 757M-€ 99M€ 476M
2024€ 796M-€ 196M€ 396M
2023€ 781M-€ 83M€ 604M
2022€ 751M-€ 175M€ 707M
2021€ 618M€ 215M€ 858M
2020€ 500M€ 6M€ 589M
2019€ 446M€ 38M€ 359M
2018€ 375M€ 84M€ 149M
2017€ 257M€ 24M€ 101M
2016€ 164M€ 27M€ 127M
2015€ 127M€ 16M€ 134M
2014€ 89M-€ 6M€ 89M
2013€ 85M-€ 25M€ 98M
2012€ 87M€ 2M€ 65M
2011€ 80M€ 6M€ 63M
2010€ 55M€ 3M€ 68M
IPO2009€ 42M-€ 45M€ 58M

Explore beyond EVO

You're looking at Evotec SE ADR. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies